CD4 and susceptibility to pneumonia measurement: These guidelines also emphasise that Toxoplasma-seropositive patients with CD4+ counts of <100 cells/μL should receive prescribed, routine treatment with trimethoprim + sulfamethoxazole or atovaquone to prevent toxoplasmic encephalitis and Pneumocystis jirovecii-associated pneumonia.